ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 031,81
0,93%
Dow Jones
38 675,68
0,00%
DAX
18 193,03
1,11%
Brent Oil
83,385
0,31%
Bitcoin
63 987,89
-0,02%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Pliant Therapeutics Inc (PLRX)

  7. Pliant Therapeutics Inc (PLRX) Actualités

PLRX Pliant Therapeutics Inc

14,31
0,33 (2,36%)
Avant marché
Dernière mise à jour : 14:00:03
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Pliant Therapeutics Inc PLRX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,33 2,36% 14,31 14:00:03
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
13,98
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
06/5/202412:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/5/202414:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
02/4/202414:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
27/3/202415:23GLOBEPliant Therapeutics Announces Upcoming Presentations at the..
12/3/202412:30GLOBEPliant Therapeutics Announces Accelerated Bexotegrast..
27/2/202422:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/2/202422:06EDGAR2Form 8-K - Current report
27/2/202422:03GLOBEPliant Therapeutics Provides Corporate Update and Reports..
26/2/202414:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
15/2/202402:55EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202414:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202414:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
05/2/202413:31EDGAR2Form 8-K - Current report
04/2/202421:29GLOBEPliant Therapeutics Announces Positive Safety and..
24/1/202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202422:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202423:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202423:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202423:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202414:00GLOBEPliant Therapeutics to Participate in the 42nd Annual J.P...
13/11/202322:30GLOBEPliant Therapeutics Presentations at The Liver Meeting® 2023..
09/11/202322:11EDGAR2Form 8-K - Current report
09/11/202322:05GLOBEPliant Therapeutics Provides Corporate Update and Reports..
08/11/202314:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
06/11/202314:00GLOBEPliant Therapeutics Presentations at the Annual Meeting of..
31/10/202321:03GLOBEPliant Therapeutics Announces Three Presentations at the..
19/10/202314:00GLOBEPliant Therapeutics INTEGRIS-PSC Phase 2a Interim Data..
16/10/202322:05GLOBEPliant Therapeutics Appoints S. Mishima Gerhart as Chief..
03/10/202322:53EDGAR2Form 8-K - Current report
26/9/202313:34EDGAR2Form 8-K - Current report
26/9/202313:30GLOBEPliant Therapeutics Announces Positive Safety and..
25/9/202322:05GLOBEPliant Therapeutics to Host Investor Call and Webcast to..
15/9/202314:00GLOBEPliant Therapeutics Appoints Minnie Kuo as Chief Development..
11/9/202314:00GLOBEPliant Therapeutics Announces Presentations at the European..
30/8/202314:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
28/8/202322:05GLOBEPliant Therapeutics Announces Three Upcoming Presentations..
09/8/202322:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202322:05EDGAR2Form 8-K - Current report
09/8/202322:03GLOBEPliant Therapeutics Provides Corporate Update and Reports..
09/8/202314:00GLOBEPliant Therapeutics Announces Initiation of BEACON-IPF, a..
25/7/202314:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
21/7/202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/7/202322:06EDGAR2Form 144 - Report of proposed sale of securities
20/7/202302:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/7/202302:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/7/202302:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202301:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202301:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
PLRX
Pliant Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés